# QIAGEN Gaithersburg, Inc clinical trials: 27 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 27 trials with QIAGEN Gaithersburg, Inc as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by QIAGEN Gaithersburg, Inc: 27 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/qiagen-gaithersburg-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 27
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 27, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 13, 2025 | NCT06824129 | Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR | QIAGEN Gaithersburg, Inc | Observational | Active not recruiting | Complicated Urinary Tract Infection | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06824129) |
| February 11, 2025 | NCT06820060 | Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel Plus | QIAGEN Gaithersburg, Inc | Observational | Active not recruiting | Meningitis, Encephalitis Infection | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06820060) |
| December 20, 2024 | NCT06745414 | Clinical Performance of QIAstat-Dx® Gastrointestinal Panel 2 | QIAGEN Gaithersburg, Inc | Observational | Completed | Gastrointestinal Infection | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06745414) |
| November 8, 2024 | NCT06681025 | Clinical Performance Evaluation of the NeuMoDx™ EBV Quant Assay 2.0 in Immunocompromised Transplant Patients | QIAGEN Gaithersburg, Inc | Observational | Completed | EBV Viremia | 1,070 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06681025) |
| October 16, 2024 | NCT06645236 | DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit | QIAGEN Gaithersburg, Inc | Not applicable | Recruiting | Metastatic Colorectal Cancer (mCRC) | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06645236) |
| April 11, 2024 | NCT06360757 | Clinical Evaluation of the NeuMoDx SARS-CoV-2 Assay (COVID-19) | QIAGEN Gaithersburg, Inc | Observational | Terminated | SARS-CoV-2 Acute Respiratory Disease | 503 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06360757) |
| February 17, 2023 | NCT05733559 | QIAstat-Dx® Respiratory Panel Plus (RPP) Clinical Performance Study | QIAGEN Gaithersburg, Inc | Observational | Completed | Respiratory Disease | 565 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05733559) |
| May 4, 2022 | NCT05360225 | Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit | QIAGEN Gaithersburg, Inc | Observational | Completed | Non Small Cell Lung Cancer | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05360225) |
| April 27, 2022 | NCT05348187 | Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit | QIAGEN Gaithersburg, Inc | Not applicable | Completed | Non-Small Cell Lung Cancer, Colorectal Cancer | 309 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05348187) |
| April 26, 2022 | NCT05347797 | Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit | QIAGEN Gaithersburg, Inc | Not applicable | Completed | Non-small Cell Lung Cancer | 495 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05347797) |
| April 26, 2022 | NCT05347745 | Therascreen® KRAS RGQ PCR Kit | QIAGEN Gaithersburg, Inc | Not applicable | Completed | Colo-rectal Cancer | 219 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05347745) |
| March 31, 2022 | NCT05305534 | QIAstat-Dx® BCID Plus AMR Panels Clinical Performance Study | QIAGEN Gaithersburg, Inc | Observational | Completed | Blood Disease | 2,142 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05305534) |
| December 17, 2021 | NCT05162547 | Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 Assay | QIAGEN Gaithersburg, Inc | Observational | Completed | Respiratory Disease | 2,383 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05162547) |
| December 13, 2021 | NCT05155553 | QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study | QIAGEN Gaithersburg, Inc | Observational | Completed | Meningitis/Encephalitis | 1,524 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05155553) |
| October 25, 2021 | NCT05092438 | QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001 | QIAGEN Gaithersburg, Inc | Observational | Completed | Meningitis/Encephalitis | 595 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05092438) |
| January 27, 2020 | NCT04243031 | QuantiFERON Access Clinical Performance Study Protocol | QIAGEN Gaithersburg, Inc | Observational | Withdrawn | Tuberculosis (TB) | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04243031) |
| April 18, 2018 | NCT03502161 | Clinical Evaluation of the QuantiFERON CMV Assay | QIAGEN Gaithersburg, Inc | Observational | Terminated | CMV | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03502161) |
| February 22, 2016 | NCT02687529 | Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection | QIAGEN Gaithersburg, Inc | Observational | Completed | Tuberculosis | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02687529) |
| April 15, 2015 | NCT02416414 | Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients | QIAGEN Gaithersburg, Inc | Observational | Terminated | Cell-mediated Immune Response | 166 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02416414) |
| October 6, 2014 | NCT02256839 | Evaluation of the QuantiFERON-TB Test. | QIAGEN Gaithersburg, Inc | Observational | Completed | Tuberculosis | 268 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02256839) |
| October 1, 2014 | NCT02253537 | Evaluation of the QuantiFERON-TB Test. | QIAGEN Gaithersburg, Inc | Observational | Completed | Tuberculosis | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02253537) |
| May 20, 2014 | NCT02142894 | Evaluation of the QuantiFERON-TB Test. | QIAGEN Gaithersburg, Inc | Observational | Completed | Tuberculosis | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02142894) |
| July 22, 2013 | NCT01904201 | Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People | QIAGEN Gaithersburg, Inc | Observational | Terminated | HIV Positive | 57 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01904201) |
| May 7, 2013 | NCT01847820 | Clinical Evaluation of the AmniSure ROM Test | QIAGEN Gaithersburg, Inc | Observational | Terminated | Rupture of Fetal Membranes | 383 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01847820) |
| February 24, 2011 | NCT01302418 | Collection and Testing of Respiratory Samples | QIAGEN Gaithersburg, Inc | Observational | Completed | QIAGEN ResPlex II Advanced Panel, Influenza A, Respiratory Syncytial Virus Infections, Infection Due to Human... | 272 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01302418) |

## By phase

| Phase | Trials |
| --- | --- |
| Not applicable | 4 |
| Observational | 23 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 18 |
| Terminated | 5 |
| Active not recruiting | 2 |
| Withdrawn | 1 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Tuberculosis | 5 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Meningitis | 3 |
| Respiration Disorders | 2 |
| Encephalitis | 2 |
| Colorectal Neoplasms | 2 |
| Influenza, Human | 2 |
| Cytomegalovirus Infections | 1 |
| Infectious Encephalitis | 1 |
| Hematologic Diseases | 1 |
| Preterm Premature Rupture of the Membranes | 1 |
| HIV Seropositivity | 1 |
| Respiratory Syncytial Virus Infections | 1 |
| Coxsackievirus Infections | 1 |
| Paramyxoviridae Infections | 1 |
| Adenoviridae Infections | 1 |
| Coronavirus Infections | 1 |
| Colonic Neoplasms | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Vocational and technical schools in the United States](https://specstream.ai/data/businesses/vocational-and-technical-schools/united-states)
- [Lodges in the United States](https://specstream.ai/data/businesses/lodges/united-states)
- [Career counseling services in the United States](https://specstream.ai/data/businesses/career-counseling-services/united-states)
- [Retina services clinics in the United States](https://specstream.ai/data/businesses/retina-services-clinics/united-states)
- [Furniture rental companies in the United States](https://specstream.ai/data/businesses/furniture-rental-companies/united-states)
- [Aircraft service companies in the United States](https://specstream.ai/data/businesses/aircraft-service-companies/united-states)
